AVCRF (Avricore Health) Moat Score: 2/10 (As of Jul. 06, 2026)


What is Avricore Health Moat Score?

Avricore Health AVCRF -13.43% Moat Score is 2 as of Jul. 06, 2026. The stock has 6 warning signs investors should review. Among 217 Medical Diagnostics & Research companies, Avricore Health ranks better than 69.59% on this metric.

Avricore Health has the Moat Score of 2, which implies that the company might have No Moat - Very weak/transient advantages.

Avricore Health has No Moat: Avricore Health Inc lacks significant market leadership or customer loyalty. The company does not possess strong intellectual property or regulatory barriers, and its market presence is limited, resulting in minimal pricing power and competitive advantages.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Avricore Health might have No Moat - Very weak/transient advantages.

Avricore Health  (OTCPK:AVCRF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Avricore Health Moat Score Related Terms

AVCRF vs TMO, DHR, IDXX: Moat Score Comparison

For the Diagnostics & Research subindustry, Avricore Health's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avricore Health Moat Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Avricore Health's Moat Score distribution charts can be found below:

* The bar in red indicates where Avricore Health's Moat Score falls into.


Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 2 mean?
Avricore Health (AVCRF) has a Moat Score of 2 as of Jul. 06, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Avricore Health ranks #66 out of 217 companies in the Medical Diagnostics & Research industry, placing it in the top 30.4%.
Is Avricore Health's Moat Score too high?
Avricore Health's current Moat Score is 2. Based on the distribution chart, Avricore Health ranks #66 out of 217 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint.
How does Avricore Health's Moat Score compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Avricore Health ranks #66 out of 217 companies for Moat Score. This puts Avricore Health in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Diagnostics & Research company?
A good Moat Score depends on the Medical Diagnostics & Research industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Avricore Health's current Moat Score is 2. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avricore Health stock overvalued right now?
Based on GuruFocus' analysis, Avricore Health (AVCRF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.02, compared to a current price of $0.03 — trading 50.5% above its estimated fair value. The current Moat Score is 2. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Avricore Health (AVCRF), the current Moat Score is 2 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avricore Health Business Description

Other Exchanges AVCR:Canada
Address 1120 - 789 West Pender Street, Vancouver, BC, CAN, V6C 1H2
Avricore Health Inc is a Canada-based company. The company is involved in the business of health data and point-of-care technologies. The company has only one segment, being the HealthTab - Point of Care Business in Canada. The company's revenues are generated from operating leases of the POCT system and the sale of testing panels. Geographically, the company operates in Canada and United Kingdom, it derives maximum revenue Canada.